TY - JOUR
T1 - Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?
AU - Masino, Susan A.
AU - Geiger, Jonathan D.
N1 - Funding Information:
The work in the Masino laboratory was supported by National Institutes of Health grants NS29173 and NS61290, a NASA EPSCoR grant to the Connecticut Space Grant College Consortium and a Howard Hughes Medical Institute institutional grant to Trinity College. The work in the Geiger laboratory was supported by grant RR017699 from the National Center for Research Resources, a component of the National Institutes of Health.
PY - 2008/6
Y1 - 2008/6
N2 - Abnormal neuronal signaling caused by metabolic changes characterizes several neurological disorders, and in some instances metabolic interventions provide therapeutic benefits. Indeed, altering metabolism either by fasting or by maintaining a low-carbohydrate (ketogenic) diet might reduce epileptic seizures and offer neuroprotection in part because the diet increases mitochondrial biogenesis and brain energy levels. Here we focus on a novel hypothesis that a ketogenic diet-induced change in energy metabolism increases levels of ATP and adenosine, purines that are critically involved in neuron-glia interactions, neuromodulation and synaptic plasticity. Enhancing brain bioenergetics (ATP) and increasing levels of adenosine, an endogenous anticonvulsant and neuroprotective molecule, might help with understanding and treating a variety of neurological disorders.
AB - Abnormal neuronal signaling caused by metabolic changes characterizes several neurological disorders, and in some instances metabolic interventions provide therapeutic benefits. Indeed, altering metabolism either by fasting or by maintaining a low-carbohydrate (ketogenic) diet might reduce epileptic seizures and offer neuroprotection in part because the diet increases mitochondrial biogenesis and brain energy levels. Here we focus on a novel hypothesis that a ketogenic diet-induced change in energy metabolism increases levels of ATP and adenosine, purines that are critically involved in neuron-glia interactions, neuromodulation and synaptic plasticity. Enhancing brain bioenergetics (ATP) and increasing levels of adenosine, an endogenous anticonvulsant and neuroprotective molecule, might help with understanding and treating a variety of neurological disorders.
UR - http://www.scopus.com/inward/record.url?scp=44549083390&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44549083390&partnerID=8YFLogxK
U2 - 10.1016/j.tins.2008.02.009
DO - 10.1016/j.tins.2008.02.009
M3 - Article
C2 - 18471903
AN - SCOPUS:44549083390
SN - 0166-2236
VL - 31
SP - 273
EP - 278
JO - Trends in Neurosciences
JF - Trends in Neurosciences
IS - 6
ER -